Trials / Completed
CompletedNCT00590317
Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Emory University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study will compare the effect of prochlorperazine and ondansetron for the treatment of nausea and vomiting in the emergency department.
Detailed description
Nausea and vomiting can be common symptoms in the emergency department (ED). Antiemetics, agents to treat nausea and vomiting, include phenothiazine derivatives, prokinetic agents, and 5-HT3 antagonists. There have been limited studies on the use of these agents in the ED, and no direct comparisons to 5-HT3 antagonists have been published to date. Inclusion Criteria: Patients presenting to the ED with at least one of the following * nausea * vomiting documented in the ED
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Prochlorperazine | Patients receiving Prochlorperazine |
| DRUG | Ondansetron | Patients receiving Ondansetron |
Timeline
- Start date
- 2005-03-01
- Primary completion
- 2008-09-01
- Completion
- 2008-09-01
- First posted
- 2008-01-10
- Last updated
- 2014-05-19
- Results posted
- 2014-05-19
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00590317. Inclusion in this directory is not an endorsement.